Response by Luo et al to Letter Regarding Article, “Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice”

Lan Luo,Tao-Sheng Li,Junnan Tang,Ke Cheng
DOI: https://doi.org/10.1161/CIRCRESAHA.117.311151
IF: 23.213
2017-01-01
Circulation Research
Abstract:We thank Takov et al for their interest in our study.1 In their letter to the editor, Takov et al raise 3 concerns regarding our study.First, Takov et al pointed out the necessity of including a vehicle control and the importance of administration technique in the in vivo mouse myocardial infarction experiments. Previous study has indicated that vehicle control and sham-operated control show similar effect on post–myocardial infarction healing.2 We completely agree with Takov et al that administration technique is important in cell transplantation. In our study, we intramyocardially inject 1×105 synthetic mesenchymal stem cell (synMSC) particles or mesenchymal stem cells (MSCs) in 50 μL PBS into 4 sites in the border zone …
What problem does this paper attempt to address?